Deerfield Management Company »

Indivior Pharmaceuticals shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Indivior Pharmaceuticals (INDV) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Indivior Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Indivior Pharmaceuticals held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indivior Pharmaceuticals by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2026-03-31 $94M 3.1M 30.48

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Brookdale Sr Living Note 3.500%10/1 (Principal)
Cogent Biosciences (COGT)
Praxis Precision Medicines I Com New (PRAX)
Viatris (VTRS)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Mirum Pharmaceuticals Note 4.000% 5/0 (Principal)
Arrowhead Pharmaceuticals In Note 1/1 (Principal)
Celcuity (CELC)
Centene Corporation (CNC)
Larimar Therapeutics (LRMR)
Brookdale Senior Living (BKD)
Vera Therapeutics Cl A (VERA)
Ionis Pharmaceuticals (IONS)

View all positions for Deerfield Management Company

Top funds holding Indivior Pharmaceuticals

BlackRock
Vanguard Portfolio Management
Oaktree Capital Management
Madison Avenue Partners
Vanguard Capital Management
Two Seas Capital
Millennium Management
Citadel Advisors
Morgan Stanley
Deerfield Management Company
Geode Capital Management
Goldman Sachs Group
UBS Group
Driehaus Capital Management
Newtyn Management

View all funds holding Indivior Pharmaceuticals